The owners
Arcutis Biotherapeutics Inc. ARQT
What the owners of this business were asked, and how they answered — from the company’s own filings. The business itself is read on the record.
The annual meeting
Held June 5, 2026. The results, as filed (8-K, Item 5.07) →
The vote on executive pay
| Votes for | 88,728,269 |
|---|---|
| Votes against | 3,723,408 |
| Abstentions | 824,860 |
| Broker non-votes | 14,868,017 |
96.0% of the votes cast for and against were cast in favor.
The advisory vote on executive compensation (“say-on-pay”), required at most US public companies since 2011; the tally is the company’s own, from the 8-K it filed after the meeting. The vote is advisory: it binds nothing, and what a board does with it is part of its record. What management is paid sits beside the business record, on the company page.